Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph E McClellan

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Analytical Chemistry|December 5, 2002
Parent and neutral loss monitoring on a quadrupole ion trap mass spectrometer: screening of acylcarnitines in complex mixturesJoseph E McClellan, Scott T Quarmby, Richard A Yost
Analytical Chemistry|August 15, 2002
Influence of charge state on product ion mass spectra and the determination of 4S/6S sulfation sequence of chondroitin sulfate oligosaccharidesJoseph E McClellan, Catherine E Costello, Peter B O'Connor, et al.
Seminars in Arthritis and Rheumatism|March 8, 2016
Development of biosimilarsAhmad Al-Sabbagh, Ewa Olech, Joseph E McClellan, et al.
Analytical Chemistry|January 29, 2002
Effects of fragile ions on mass resolution and on isolation for tandem mass spectrometry in the quadrupole ion trap mass spectrometerJoseph E McClellan, James P Murphy, Joseph J Mulholland, et al.
Therapeutic Advances in Chronic Disease|January 22, 2024
The totality of evidence approach in the development of AVT02 (adalimumab), a biosimilar to HumiraJoseph E McClellan, Sesselja Ómarsdóttir, Nivedita Roy, et al.
Therapeutic Advances in Gastroenterology|June 22, 2019
The 'totality-of-the-evidence' approach in the development of PF-06438179/GP1111, an infliximab biosimilar, and in support of its use in all indications of the reference productJoseph E McClellan, Hugh D Conlon, Michael W Bolt, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Analytical Chemistry|December 5, 2002
Parent and neutral loss monitoring on a quadrupole ion trap mass spectrometer: screening of acylcarnitines in complex mixturesJoseph E McClellan, Scott T Quarmby, Richard A Yost
Analytical Chemistry|August 15, 2002
Influence of charge state on product ion mass spectra and the determination of 4S/6S sulfation sequence of chondroitin sulfate oligosaccharidesJoseph E McClellan, Catherine E Costello, Peter B O'Connor, et al.
Seminars in Arthritis and Rheumatism|March 8, 2016
Development of biosimilarsAhmad Al-Sabbagh, Ewa Olech, Joseph E McClellan, et al.
Analytical Chemistry|January 29, 2002
Effects of fragile ions on mass resolution and on isolation for tandem mass spectrometry in the quadrupole ion trap mass spectrometerJoseph E McClellan, James P Murphy, Joseph J Mulholland, et al.
Therapeutic Advances in Chronic Disease|January 22, 2024
The totality of evidence approach in the development of AVT02 (adalimumab), a biosimilar to HumiraJoseph E McClellan, Sesselja Ómarsdóttir, Nivedita Roy, et al.
Therapeutic Advances in Gastroenterology|June 22, 2019
The 'totality-of-the-evidence' approach in the development of PF-06438179/GP1111, an infliximab biosimilar, and in support of its use in all indications of the reference productJoseph E McClellan, Hugh D Conlon, Michael W Bolt, et al.
Pageof 1